Business Development Manager at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, Healthcare InnovationIndustries

Requirements

Bachelor's degree in Business, Finance, Life Sciences, or a related field
Minimum of 5 years of experience in corporate development, investment banking, consulting, or life sciences business development roles
Track record of structuring and executing complex transactions, including licensing agreements, M&A, or strategic partnerships

Responsibilities

Spearhead market scanning and intelligence gathering to proactively identify and engage potential strategic partners
Work with internal R&D and product teams to assess the strategic fit and technical feasibility of collaboration models
Conduct comprehensive market research and competitive analysis to identify high-value market segments and potential partners
Lead and support all aspects of transaction execution, including due diligence, term sheet development, and contract negotiations
Develop financial models to assess the potential financial impact of business development initiatives
Prepare and deliver compelling investment theses and deal presentations
Manage outside consultants and coordinate internal diligence efforts
Serve as a key liaison for external stakeholders and internal cross-functional teams
Drive and manage internal consensus by aligning stakeholders and assigning clear deliverables
Own the contracting and governance model for partnerships

Skills

Business Development

Strategic Partnerships

Financial Analysis

Partnership Management

Cross-functional Team Leadership

Market Scanning

Deal Execution

Relationship Management

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free